Cannabidiol in the Treatment of Post-Traumatic Stress Disorder: A Case Series
Author(s) -
Lucas Elms,
Scott Shan,
Shan Hughes,
Nicole Lewis
Publication year - 2018
Publication title -
the journal of alternative and complementary medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.55
H-Index - 90
eISSN - 1557-7708
pISSN - 1075-5535
DOI - 10.1089/acm.2018.0437
Subject(s) - medicine , traumatic stress , series (stratigraphy) , cannabidiol , psychiatry , cannabis , paleontology , biology
Cannabidiol (CBD) is a non-psychotomimetic cannabinoid compound that is found in plants of the genus Cannabis. Preclinical research has suggested that CBD may have a beneficial effect in rodent models of post-traumatic stress disorder (PTSD). This effect is believed to be due to the action of CBD on the endocannabinoid system. CBD has seen a recent surge in research regarding its potential value in a number of neuro-psychiatric conditions. This is the first study to date examining the clinical benefit of CBD for patients with PTSD.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom